Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis

Biochemistry

Volumn 44, Issue 33, 2005, Pages 11122-11129

  Saito, Shiori ^a   Ando, Yukio ^b   Nakamura, Masaaki ^b   Ueda, Mitsuharu ^b   Kim, Jaemi ^a   Ishima, Yu ^a   Akaike, Takaaki ^b   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CONFORMATIONS; MUSCLE; NITROGEN COMPOUNDS; OXIDATION; PROTEINS;

FIBRILS; OXIDATIVE STRESS; PRECURSORS; TETRAMERS;

BIOCHEMISTRY;

AMYLOID; CYSTEINE; NITRIC OXIDE; PREALBUMIN; PROTEIN PRECURSOR; TETRAMER;

ACIDITY; AMYLOIDOSIS; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; FAMILIAL AMYLOID POLYNEUROPATHY; HUMAN; IN VITRO STUDY; NITROSYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN STABILITY; SMOOTH MUSCLE FIBER; STRUCTURE ANALYSIS; WILD TYPE;

AMINO ACID SUBSTITUTION; AMYLOID; AMYLOIDOSIS; ENDOTHELIAL CELLS; HUMANS; METHIONINE; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; OXIDATION-REDUCTION; POINT MUTATION; PREALBUMIN; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; VALINE;

EID: 23944483446     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi050327i     Document Type: Article

References (45)

1. Pepys, M. B., Hawkins, P. N., Booth, D. R., Vigushin, D. M., Tennent, G. A., Soutar, A. K., Totty, N., Nguyen, O., Blake, C. C., Terry, C. J., Feest, T. G., Zalin, A. M., and Hsuan, J. J. (1993) Human lysozyme gene mutations cause hereditary systemic amyloidosis, Nature 362, 553-557.
2. Westermark, P., Bergstrom, J., Solomon, A., Murphy, C., and Sletten, K. (2003) Transthyretin-derived senile systemic amyloidosis: Clinicopathologic and structural considerations, Amyloid 10, 48-54.
3. Benson, M. D., and Uemichi, T. (1996) Transthyretin amyloidosis, Amyloid 3, 44-56.
4. Ando, Y., Araki, S., and Ando, M. (1993) Transthyretin and familial amyloidotic polyneuropathy, Intern. Med. (Tokyo, Jpn.) 32, 920-922.
5. Ando, Y., Nakamura, M., and Araki, S. (2005) Transthyretin related familial amyloidotic polyneuropathy, Arch. Neurol. 62, 1-6.
6. Holmgren, G., Steen, L., Suhr, O., Ericzon, B. G., Groth, C. G., Andersen, O., Wallin, B. G., Seymour, A., Richardson, S., Hawkins, P. N., and Pepys, M. B. (1993) Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis, Lancet 341, 1113-1116.
7. Ando, Y., Tanaka, Y., Nakazato, M., Ericzon, B. G., Yamashita, T., Tashima, K., Sakashita, N., Suga, M., Uchino, M., and Ando, M. (1995) Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation, Biochem. Biophys. Res. Commun. 211, 354-358.
8. Ando, Y., Tanaka, Y., Ando, E., Yamashita, T., Nishida, Y., Tashima, Y., Suga, M., Uchino, M., and Ando, M. (1995) Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I, Lancet 345, 195-196.
9. Skinner, M., Lewis, W. D., Jones, L. A., Kasirsky, J., Kane, K., Ju, S. T., Jenkins, R., Falk, R. H., Simms, R. W., and Cohen, A. S. (1994) Liver transplantation as a treatment for familial amyloidotic polyneuropathy, Ann. Intern. Med. 120, 133-134.
10. Cornwell, G. G., III, Sletten, K., Johansson, B., and Westermark, P. (1988) Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin, Biochem. Biophys. Res. Commun. 154, 648-653.
11. Schoneich, C. (2002) Redox processes of methionine relevant to β-amyloid oxidation and Alzheimer's disease. Arch. Biochem. Biophys. 397, 370-376.
12. Rosenblum, W. I. (2002) Structure and location of amyloid β peptide chains and arrays in Alzheimer's disease: New findings require reevaluation of the amyloid hypothesis and of tests of the hypothesis, Neurobiol. Aging 23, 225-230.
13. Descamps-Latscha, B., Jungers, P., and Witko-Sarsat, V. (2002) Immune system dysregulation in uremia: Role of oxidative stress, Blood Purif. 20, 481-484.
14. Ando, Y., Nyhlin, N., Suhr, O., Holmgren, G., Uchida, K., El-Sahly, M., Yamashita, T., Terasaki, H., Nakamura, M., Uchino, M., and Ando, M. (1997) Oxidative stress is found in amyloid deposits in systemic amyloidosis, Biochem. Biophys. Res. Commun. 232, 497-502.
15. Suhr, O., Lang, K., Wikstrom, L., Anan, I., Ando, Y., El-Salhy, M., Holmgren, G., and Tashima, K. (2001) Scavenger treatment of free radical injury in familial amyloidotic polyneuropathy: A study on Swedish transplanted and non-transplanted patients, Scand. J. Clin. Lab. Invest. 61, 11-18.
16. Ferdinandy, P. (2004) Nitric oxide and peroxynitrite in cardioprotection: The effect of hyperlipidaemia, Cardiovasc. J. S. Afr. 15, S4.
17. Berg, D., Youdim, M. B., and Riederer, P. (2004) Redox imbalance, Cell Tissue Res. 318, 201-213.
18. Akaike, T., and Maeda, H. (2000) Nitric oxide and virus infection, Immunology 101, 300-308.
19. Kikugawa, K., Hiramoto, K., and Ohkawa, T. (2004) Effects of oxygen on the reactivity of nitrogen oxide species including peroxynitrite, Biol. Pharm. Bull. 27, 17-23.
20. McCutchen, S. L., Lai, Z., Miroy, G. J., Kelly, J. W., and Colon, W. (1995) Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease, Biochemistry 34, 13527-13536.
21. Kelly, J. W., Colon, W., Lai, Z., Lashuel, H. A., McCulloch, J., McCulloch, S. L., Miroy, G. J., and Peterson, P. A. (1997) Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid, Adv. Protein Chem. 50, 161-181.
22. Ando, Y., Ohlsson, P. I., Suhr, O., Nyhlin, N., Yamashita, T., Holmgren, G., Danielsson, A., Sansgren, O., Uchino, M., and Ando, M. (1996) A new simple and rapid screening method for variant transthyretin-related amyloidosis, Biochem. Biophys. Res. Commun. 228, 480-483.
23. Kishikawa, M., Nakanishi, T., Miyazaki, A., Shimizu, A., Kusaka, H., Fukui, M., and Nishiue, T. (1999) A new amyloidogenic transthyretin variant, [D38A], detected by electrospray ionization/mass spectrometry, Amyloid 6, 183-186.
24. Takaoka, Y., Ohta, M., Miyakawa, K., Nakamura, O., Suzuki, M., Takahashi, K., Yamamura, K., and Sakaki, Y. (2004) Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met, Am. J. Pathol. 164, 337-345.
25. Zhang, Q., and Kelly, J. W. (2003) Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions, Biochemistry 42, 8756-8761.
26. Sousa, M. M., Fernandes, R., Palha, J. A., Taboada, A., Vieira, P., and Saraiva, M. J. (2002) Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro. Am. J. Pathol. 161, 1935-1948.
27. Ando, Y., Yamashita, T., Nakamura, M., Tanaka, Y., Hashimoto, M., Tashima, K., Suhr, O., Uemura, Y., Obayashi, K., Terazaki, H., Suga, M., Uchino, M., and Ando, M. (1997) Down regulation of a harmful variant protein by replacement of its normal protein, Biochim. Biophys. Acta 1362, 39-46.
28. Hermansen, L. F., Bergman, T., Jornvall, H., Husby, G., Ranlov, I., and Sletten, K. (1995) Purification and characterization of amyloid-related transthyretin associated with familial amyloidotic cardiomyopathy, Eur. J. Biochem. 227, 772-779.
29. Quintas, A., Saraiva, M. J., and Brito, R. M. (1997) The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution, FEBS Lett. 418, 297-300.
30. 1-protease inhibitor. Biochim. Biophys. Acta 1477, 90-97.
31. Akaike, T. (2000) Mechanisms of biological S-nitrosation and its measurement, Free Radical Res. 33, 461-469.
32. Inoue, K., Akaike, T., Miyamoto, Y., Okamoto, T., Sawa, T., Otagiri, M., Suzuki, S., Yoshimura, T., and Maeda, H. (1999) Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo, J. Biol. Chem. 274, 27069-27075.
33. Takabayashi, K., Imada, T., Saito, Y., and Inada, Y. (1983) Coupling between fatty acid binding and sulfhydryl oxidation in bovine serum albumin, Eur. J. Biochem. 136, 291-295.
34. Akaike, T., Inoue, K., Okamoto, T., Nishino, H., Otagiri, M., Fujii, S., and Maeda, H. (1997) Nanomolar quantification and identification of various nitrosothiols by high performance liquid chromatography coupled with flow reactors of metals and Griess reagent, J. Biochem. 122, 459-466.
35. Saville, B. (1958) A scheme for the colorimetric determination of microgram amounts of thiols, Analyst 83, 670-672.
36. Goldberg, M. E., Rudolph, R., and Jaenicke, R. (1991) A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme, Biochemists 30, 2790-2797.
37. Bonifacio, M. J., Sasaki, Y., and Saraiva, M. J. (1996) 'In vitro' amyloid fibril formation from transthyretin: The influence of ions and the amyloidogenicity of TTR variants, Biochim. Biophys. Acta 1316, 35-42.
38. Naiki, H., Higuchi, K., Hosokawa, M., and Takeda, T. (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1, Anal. Biochem. 177, 244-249.
39. del Rio, L. A., Corpas, F. J., Sandalio, L. M., Palma, J. M., Gomez, M., and Barroso, J. B. (2002) Reactive oxygen species, antioxidant systems and nitric oxide in peroxisomes, J. Exp. Bot. 53, 1255-1272.
40. Mirza, U. A., Chait, B. T., and Lander, H. M. (1995) Monitoring reactions of nitric oxide with peptides and proteins by electrospray ionization-mass spectrometry, J. Biol. Chem. 270, 17185-17188.
41. Skinner, M., Stone, P., Shirahama, T., Connors, L. H., Calore, J., and Cohen, A. S. (1986) The association of an elastase with amyloid fibrils, Proc. Soc. Exp. Biol. Med. 181, 211-214.
42. Jiang, X., Buxbaum, J. N., and Kelly, J. W. (2001) The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis, Proc. Natl. Acad. Sci. U.S.A. 98, 14943-14948.
43. Jaffrey, S. R., Erdjument-Bromage, H., Ferris, C. D., Tempst, P., and Snyder, S. H. (2001) Protein S-nitrosylation: A physiological signal for neuronal nitric oxide, Nat. Cell Biol. 3, 193-197.
44. Foster, M. W., McMahon, T. J., and Stamler, J. S. (2003) S-nitrosylation in health and disease, Trends Mol. Med. 9, 160-168.
45. Jia, L., Bonaventura, C., Bonaventura, J., and Stanler, J. S. (1996) S-nitrosohaemoglobin: A dynamic activity of blood involved in vascular control, Nature 380, 221-226.